Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.30 | N/A |
| PEG Ratio (TTM) | -1.36 | N/A |
| P/S Ratio (TTM) | 0.21 | N/A |
| P/B Ratio (TTM) | 0.90 | N/A |
| P/FCF Ratio (TTM) | 6.11 | N/A |
| Price to 5YR AVG Earnings Ratio | 24.12 | N/A |
| Price to 5YR AVG FCF Ratio | 4.45 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.23% | N/A |
| ROE (TTM) | 8.14% | N/A |
| Net Profit Margin (TTM) | 1.93% | N/A |
| ROIC 5YR AVG | 6.44% | N/A |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 49.43% | -70.40% | -4.27% |
| Revenue | 1.60% | -4.66% | 2.68% |
| Net Income | 48.89% | -70.35% | -4.21% |
| Cash Flow | 51.86% | 6.69% | 16.23% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.15 | N/A |
| Quick Ratio (TTM) | 0.98 | N/A |
| D/E Ratio (TTM) | 3.55 | N/A |
| Interest Coverage (TTM) | 3.01 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.01 | N/A |
| LTL to 5YR AVG FCF | 11.28 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.22% | N/A |